HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 69 filers reported holding HARVARD BIOSCIENCE INC in Q4 2022. The put-call ratio across all filers is 102.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,207,818 | -16.1% | 2,141,353 | +7.1% | 10.12% | -19.4% |
| Q2 2023 | $10,980,000 | +27.3% | 2,000,000 | -2.6% | 12.55% | +27.0% |
| Q1 2023 | $8,626,409 | +38.2% | 2,053,907 | -8.9% | 9.88% | +6.7% |
| Q4 2022 | $6,243,322 | +50.5% | 2,253,907 | +39.1% | 9.26% | +47.9% |
| Q3 2022 | $4,149,000 | -7.8% | 1,620,783 | +29.7% | 6.26% | -19.3% |
| Q2 2022 | $4,500,000 | -6.7% | 1,250,000 | +61.0% | 7.76% | +55.3% |
| Q1 2022 | $4,821,000 | -14.5% | 776,253 | -3.0% | 5.00% | -36.2% |
| Q4 2021 | $5,640,000 | – | 800,000 | – | 7.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AMH Equity Ltd | 2,053,907 | $8,626,409 | 9.88% |
| B. Riley Asset Management, LLC | 3,408,796 | $14,316,943 | 5.93% |
| Meros Investment Management, LP | 1,124,206 | $4,721,665 | 2.69% |
| Harvey Partners, LLC | 2,712,700 | $11,393,340 | 1.41% |
| Archon Capital Management LLC | 1,361,769 | $5,719,430 | 1.28% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 2,947,329 | $12,378,782 | 0.80% |
| BARD ASSOCIATES INC | 291,297 | $1,223,448 | 0.50% |
| Portolan Capital Management | 1,043,546 | $4,382,893 | 0.42% |
| HEARTLAND ADVISORS INC | 1,200,000 | $5,040,000 | 0.31% |
| EAM Investors, LLC | 345,546 | $1,451,293 | 0.28% |